Home / Ophthalmology
Ophthalmology
| 3 min read
Ocugen’s gene therapy candidate shows potential in five different models of retinitis pigmentosa
| 3 min read
Two new cell models for ocular drug discovery could reduce the need for animal testing
| 3 min read
Adverum’s wet AMD candidate helps maintain vision in Phase 1 trial
| 2 min read
Clearside announces option exercise by REGENXBIO for gene therapy delivery tech
| 4 min read
A trio of companies report trial progression or positive data for AMD-targeted therapeutics
| 3 min read
GenSight reports marked visual improvement in Phase 3 study of rare eye disease
| 2 min read
RegeneRx partner receives patent for new ophthalmic formulation of thymosin beta 4
| 3 min read
Mannin Research, Biointerfaces Institute to pursue GDF15 biomarker diagnostic for eye disease
| 2 min read
Adverum presents first preclinical data on dosing contralateral eye with ADVM-022
| 3 min read
Study confirms intraocular pressure-lowering effects, proving promising novel treatment for glaucoma
| 3 min read
Company announces agreement to acquire Nightstar Therapeutics
